ISSAR Pharma announces out-licensing of its peptide-based NCEs EP News Bureau Apr 20, 2021 ISSAR has several patents for peptide molecules lined up in their development pipeline targeting therapeutic areas such as…
Suven Life Sciences secures two product patents in Australia and Canada Sanjiv Das Feb 19, 2016 The patents correspond to the NCEs for the treatment of disorders associated with neurodegenerative diseases Suven Life Sciences…
Suven Life Sciences secures five product patents Sanjiv Das Sep 10, 2015 The granted claims of the patents from China, Israel, Mexico, Singapore, Sri Lanka include the class of selective 5-HT compounds…
